Disclosures for "Preliminary Findings on Serum Neurofilament Light Chain and Slow Vital Capacity in ALS Patients Treated With Edaravone: A Single-center Experience"
-
Ms. Alayon has nothing to disclose.
-
Dr. Harmon has nothing to disclose.
-
Dr. Leon has nothing to disclose.
-
Dr. Godeiro Coelho has nothing to disclose.
-
Dr. Cabrera Pulla has nothing to disclose.
-
Dr. Roberts has nothing to disclose.
-
The institution of Dr. Carbunar has received research support from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The institution of Dr. Carbunar has received research support from ARGENX/PPD.